Commission discusses barriers to opioid treatment following overdose reversals in emergency care

During a recent San Francisco government meeting, a critical discussion emerged surrounding the city's response to the opioid crisis, particularly the challenges in administering buprenorphine to overdose survivors. The conversation highlighted a concerning statistic: only 10% of individuals who experience nonfatal overdoses are accepting buprenorphine, a medication essential for treating opioid use disorder.

Chief Nicholson explained that the process of getting patients on buprenorphine is complex and time-consuming. After receiving Narcan, which reverses an overdose, patients often experience withdrawal symptoms and may be reluctant to engage in treatment. The current protocol requires emergency room doctors to prescribe buprenorphine, but many are hesitant without ensuring follow-up care, which the city’s team provides.

The process involves accompanying patients to emergency rooms and pharmacies, a lengthy ordeal that can deter individuals from completing treatment. Chief Nicholson expressed optimism that proposed changes to local regulations could streamline this process, allowing for buprenorphine to be administered immediately after Narcan use. However, he noted that these regulatory changes could take several months to implement due to bureaucratic procedures.

The meeting underscored the urgency of addressing the opioid crisis in San Francisco, with officials acknowledging the need for more efficient treatment pathways to improve the low acceptance rates of buprenorphine among overdose survivors. As the city navigates these challenges, the hope is that forthcoming policy changes will enhance access to life-saving medications and ultimately save lives.